While DOCK4 regulates formation of cellular junctions and is disrupted in prostate and ovarian cancers,SPARCL1 acts as a negative regulator of cell proliferation and its down-regulation is detected in prostate, colon, and non-small cell lung carcinomas [32,34,35]. The gene discussed is DOCK4; the disease is ovarian carcinoma.